Published in J Med Chem on August 12, 2004
Low Serum 25-Hydroxyvitamin D Levels Are Associated with Dry Eye Syndrome. PLoS One (2016) 0.79
Discovery of Immunodominant B Cell Epitopes within Surface Pneumococcal Virulence Proteins in Pediatric Patients with Invasive Pneumococcal Disease. J Biol Chem (2015) 0.76
Diagnostic potential of zinc finger protein-specific autoantibodies and associated linear B-cell epitopes in colorectal cancer. PLoS One (2015) 0.75
The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med (2005) 3.26
Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med (2004) 3.03
Treatment of primary Sjögren syndrome: a systematic review. JAMA (2010) 2.37
Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS. J Rheumatol (2008) 2.05
Morbidity, mortality, and organ damage in patients with antiphospholipid syndrome. J Rheumatol (2012) 1.97
Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med (2005) 1.93
Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome. Arthritis Rheum (2004) 1.92
Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum (2004) 1.87
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial. Ann Rheum Dis (2007) 1.83
Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J Autoimmun (2007) 1.71
Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med (2007) 1.64
Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum (2007) 1.62
Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum (2002) 1.59
{beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome. Blood (2009) 1.47
Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus. J Rheumatol (2008) 1.47
Classification criteria for Sjogren's syndrome: a critical review. J Autoimmun (2011) 1.46
Salivary gland epithelial cell exosomes: A source of autoantigenic ribonucleoproteins. Arthritis Rheum (2005) 1.45
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome. Nat Rev Rheumatol (2010) 1.43
Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis. Clin Exp Rheumatol (2012) 1.41
Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome. J Autoimmun (2009) 1.39
Longterm followup after tapering mycophenolate mofetil during maintenance treatment for proliferative lupus nephritis. J Rheumatol (2011) 1.39
Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging. Arthritis Rheum (2003) 1.38
The geoepidemiology of Sjögren's syndrome. Autoimmun Rev (2009) 1.37
Pathogenesis of Sjögren's syndrome: what we know and what we should learn. J Autoimmun (2012) 1.35
Evidence for coxsackievirus infection in primary Sjögren's syndrome. Arthritis Rheum (2004) 1.29
Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis. Arthritis Res Ther (2010) 1.23
Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors. Am J Pathol (2008) 1.23
Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum (2006) 1.21
Topical and systemic medications for the treatment of primary Sjögren's syndrome. Nat Rev Rheumatol (2012) 1.19
Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I. Arthritis Rheum (2011) 1.18
Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthritis Rheum (2009) 1.17
Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease. J Rheumatol (2002) 1.17
Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) (2009) 1.17
Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes. Clin Cancer Res (2007) 1.16
Sjögren's syndrome--study of autoantigens and autoantibodies. Clin Rev Allergy Immunol (2007) 1.16
Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue. Ann Rheum Dis (2012) 1.14
The management of Sjögren's syndrome. Nat Clin Pract Rheumatol (2006) 1.12
Sjögren's syndrome. Annu Rev Pathol (2013) 1.10
Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases. Proc Natl Acad Sci U S A (2012) 1.10
Prognosis and outcome of non-Hodgkin lymphoma in primary Sjögren syndrome. Medicine (Baltimore) (2012) 1.09
Idiotype-anti-idiotype circuit in non-autoimmune mice after immunization with the epitope and complementary epitope 289-308aa of La/SSB: implications for the maintenance and perpetuation of the anti-La/SSB response. J Autoimmun (2003) 1.09
Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases. J Autoimmun (2006) 1.07
Selective screening of secretory vesicle-associated proteins for autoantigens in type 1 diabetes: VAMP2 and NPY are new minor autoantigens. Clin Immunol (2008) 1.06
Conventional therapy of Sjogren's syndrome. Clin Rev Allergy Immunol (2007) 1.05
Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study. Arthritis Res Ther (2011) 1.04
Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens. Clin Ther (2008) 1.02
Autoantibodies to intracellular autoantigens and their B-cell epitopes: molecular probes to study the autoimmune response. Crit Rev Clin Lab Sci (2006) 1.00
The liver in brucellosis. Clin Gastroenterol Hepatol (2007) 1.00
Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline. Arthritis Rheum (2006) 0.99
Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. J Rheumatol (2002) 0.98
Wound healing: immunological aspects. Injury (2006) 0.98
Unmasking the anti-La/SSB response in sera from patients with Sjogren's syndrome by specific blocking of anti-idiotypic antibodies to La/SSB antigenic determinants. Mol Med (2002) 0.98
Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings. Arch Intern Med (2006) 0.98
Hepatitis C virus, Sjögren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun Rev (2005) 0.97
Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: risks, management, and prognosis. Rheum Dis Clin North Am (2008) 0.97
Establishment of a convenient system for the long-term culture and study of non-neoplastic human salivary gland epithelial cells. Eur J Oral Sci (2002) 0.96
Prevalence of hepatitis C serum antibody in autoimmune diseases. J Autoimmun (2009) 0.94
IgG4 syndrome: old disease, new perspective. J Rheumatol (2010) 0.94
Neuroendocrine dysfunction in Sjogren's syndrome. Neuroimmunomodulation (2008) 0.94
The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases. Clin Chim Acta (2004) 0.92
Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome. Arthritis Rheum (2013) 0.91
Cellular microRNAs (miRNAs) and Sjögren's syndrome: candidate regulators of autoimmune response and autoantigen expression. J Autoimmun (2011) 0.91
Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjögren's syndrome. J Autoimmun (2012) 0.91
Autoimmune response and target autoantigens in Sjogren's syndrome. Eur J Clin Invest (2010) 0.90
Immunologic factors in the pathogenesis of osteonecrosis. Orthop Clin North Am (2004) 0.90
Lymphoproliferation in autoimmunity and Sjögren's syndrome. Curr Rheumatol Rep (2003) 0.89
The role of chaperone proteins in autoimmunity. Ann N Y Acad Sci (2006) 0.88
Prevalence and longterm course of primary biliary cirrhosis in primary Sjögren's syndrome. J Rheumatol (2008) 0.88
Migration of bisphenol A from polycarbonate baby bottles under real use conditions. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2008) 0.88
Mapping the binding domains of the alpha(IIb) subunit. A study performed on the activated form of the platelet integrin alpha(IIb)beta(3). Eur J Biochem (2003) 0.88
Endocrine alterations in primary Sjogren's syndrome: an overview. J Autoimmun (2012) 0.88
Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis. Am J Kidney Dis (2003) 0.87
Autoantibodies in Sjögren's syndrome: clinical presentation and regulatory mechanisms. Presse Med (2012) 0.87
Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients. PLoS One (2013) 0.87
RNA recognition motif (RRM) of La/SSB: the bridge for interparticle spreading of autoimmune response to U1-RNP. Mol Med (2009) 0.87
Sjögren's Syndrome. Semin Respir Crit Care Med (2007) 0.87
Sjogren's syndrome. Autoimmunity (2004) 0.87
Determinants of pulmonary arterial hypertension in scleroderma. Semin Arthritis Rheum (2007) 0.86
The transcriptional ETS2 repressor factor associates with active and inactive Erks through distinct FXF motifs. J Biol Chem (2006) 0.86
Fine epitope specificity of anti-erythropoietin antibodies reveals molecular mimicry with HIV-1 p17 protein: a pathogenetic mechanism for HIV-1-related anemia. J Infect Dis (2011) 0.86
The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): a small pilot study. J Neurol Sci (2013) 0.86
Is Sjögren's syndrome a retroviral disease? Arthritis Res Ther (2011) 0.86